\documentclass[10pt,a4paper]{article} % Packages \usepackage{fancyhdr} % For header and footer \usepackage{multicol} % Allows multicols in tables \usepackage{tabularx} % Intelligent column widths \usepackage{tabulary} % Used in header and footer \usepackage{hhline} % Border under tables \usepackage{graphicx} % For images \usepackage{xcolor} % For hex colours %\usepackage[utf8x]{inputenc} % For unicode character support \usepackage[T1]{fontenc} % Without this we get weird character replacements \usepackage{colortbl} % For coloured tables \usepackage{setspace} % For line height \usepackage{lastpage} % Needed for total page number \usepackage{seqsplit} % Splits long words. %\usepackage{opensans} % Can't make this work so far. Shame. Would be lovely. \usepackage[normalem]{ulem} % For underlining links % Most of the following are not required for the majority % of cheat sheets but are needed for some symbol support. \usepackage{amsmath} % Symbols \usepackage{MnSymbol} % Symbols \usepackage{wasysym} % Symbols %\usepackage[english,german,french,spanish,italian]{babel} % Languages % Document Info \author{FCGLITCHES} \pdfinfo{ /Title (adrenergic-drugs.pdf) /Creator (Cheatography) /Author (FCGLITCHES) /Subject (Adrenergic Drugs Cheat Sheet) } % Lengths and widths \addtolength{\textwidth}{6cm} \addtolength{\textheight}{-1cm} \addtolength{\hoffset}{-3cm} \addtolength{\voffset}{-2cm} \setlength{\tabcolsep}{0.2cm} % Space between columns \setlength{\headsep}{-12pt} % Reduce space between header and content \setlength{\headheight}{85pt} % If less, LaTeX automatically increases it \renewcommand{\footrulewidth}{0pt} % Remove footer line \renewcommand{\headrulewidth}{0pt} % Remove header line \renewcommand{\seqinsert}{\ifmmode\allowbreak\else\-\fi} % Hyphens in seqsplit % This two commands together give roughly % the right line height in the tables \renewcommand{\arraystretch}{1.3} \onehalfspacing % Commands \newcommand{\SetRowColor}[1]{\noalign{\gdef\RowColorName{#1}}\rowcolor{\RowColorName}} % Shortcut for row colour \newcommand{\mymulticolumn}[3]{\multicolumn{#1}{>{\columncolor{\RowColorName}}#2}{#3}} % For coloured multi-cols \newcolumntype{x}[1]{>{\raggedright}p{#1}} % New column types for ragged-right paragraph columns \newcommand{\tn}{\tabularnewline} % Required as custom column type in use % Font and Colours \definecolor{HeadBackground}{HTML}{333333} \definecolor{FootBackground}{HTML}{666666} \definecolor{TextColor}{HTML}{333333} \definecolor{DarkBackground}{HTML}{A3A3A3} \definecolor{LightBackground}{HTML}{F3F3F3} \renewcommand{\familydefault}{\sfdefault} \color{TextColor} % Header and Footer \pagestyle{fancy} \fancyhead{} % Set header to blank \fancyfoot{} % Set footer to blank \fancyhead[L]{ \noindent \begin{multicols}{3} \begin{tabulary}{5.8cm}{C} \SetRowColor{DarkBackground} \vspace{-7pt} {\parbox{\dimexpr\textwidth-2\fboxsep\relax}{\noindent \hspace*{-6pt}\includegraphics[width=5.8cm]{/web/www.cheatography.com/public/images/cheatography_logo.pdf}} } \end{tabulary} \columnbreak \begin{tabulary}{11cm}{L} \vspace{-2pt}\large{\bf{\textcolor{DarkBackground}{\textrm{Adrenergic Drugs Cheat Sheet}}}} \\ \normalsize{by \textcolor{DarkBackground}{FCGLITCHES} via \textcolor{DarkBackground}{\uline{cheatography.com/192245/cs/39995/}}} \end{tabulary} \end{multicols}} \fancyfoot[L]{ \footnotesize \noindent \begin{multicols}{3} \begin{tabulary}{5.8cm}{LL} \SetRowColor{FootBackground} \mymulticolumn{2}{p{5.377cm}}{\bf\textcolor{white}{Cheatographer}} \\ \vspace{-2pt}FCGLITCHES \\ \uline{cheatography.com/fcglitches} \\ \end{tabulary} \vfill \columnbreak \begin{tabulary}{5.8cm}{L} \SetRowColor{FootBackground} \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Cheat Sheet}} \\ \vspace{-2pt}Published 23rd August, 2023.\\ Updated 23rd August, 2023.\\ Page {\thepage} of \pageref{LastPage}. \end{tabulary} \vfill \columnbreak \begin{tabulary}{5.8cm}{L} \SetRowColor{FootBackground} \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Sponsor}} \\ \SetRowColor{white} \vspace{-5pt} %\includegraphics[width=48px,height=48px]{dave.jpeg} Measure your website readability!\\ www.readability-score.com \end{tabulary} \end{multicols}} \begin{document} \raggedright \raggedcolumns % Set font size to small. Switch to any value % from this page to resize cheat sheet text: % www.emerson.emory.edu/services/latex/latex_169.html \footnotesize % Small font. \begin{multicols*}{3} \begin{tabularx}{5.377cm}{x{1.64241 cm} x{3.33459 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Introduction}} \tn % Row 0 \SetRowColor{LightBackground} {\bf{Adrenergic drugs}} & release acetylcholine at the post synaptic level. Only post ganglionic sypathetic nerves are adrenergic as they use epinephrine as neuron transmitters. \tn % Row Count 6 (+ 6) % Row 1 \SetRowColor{white} {\bf{Function}} & Norepinephrine is a neurotransmitter of adrenergic synapse, coming from tyrosine → DOPA → Dopamine, stored in vesicles until it needs to be released, when impulses from CNS send the signals. They use exocytosis so the norepinephrine gets into the synaptic cleft. In synaptic cleft, norepinephrine needs to act on post synaptic receptors. \tn % Row Count 20 (+ 14) % Row 2 \SetRowColor{LightBackground} & Norepinephrine is released from the presynaptic membrane 1) Most of it is taken back w/out any changes to be reused (uptake 1), \{\{nl\}\} 2) Taken by factors cells AKA non neuronal uptake (uptake 2) \{\{nl\}\} 3) Diffuse \{\{nl\}\} 4) Degrade (by enzyme present in the synaptic left, minor). \tn % Row Count 31 (+ 11) \end{tabularx} \par\addvspace{1.3em} \vfill \columnbreak \begin{tabularx}{5.377cm}{x{1.64241 cm} x{3.33459 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Introduction (cont)}} \tn % Row 3 \SetRowColor{LightBackground} & Norepinephrine can act on presynaptic receptors, regulate release of Norepinephrine from sympathetic nerve endings (AKA alpha 2 receptors), regulates -ive feedback mechanism (uptake 1) \tn % Row Count 8 (+ 8) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{1.84149 cm} x{3.13551 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Drugs - based on potency}} \tn % Row 0 \SetRowColor{LightBackground} {\bf{α-adrenoceptors}} & Norepinephrine → epinephrine → isoprenaline \tn % Row Count 2 (+ 2) % Row 1 \SetRowColor{white} {\bf{β-adrenoceptors}} & Isoprenaline → epinephrine → norepinephrine \tn % Row Count 4 (+ 2) % Row 2 \SetRowColor{LightBackground} {\bf{α,β adrenoceptors}} & Epinephrine + norepinephrine \tn % Row Count 6 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{1.69218 cm} x{3.28482 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Groups of drugs}} \tn % Row 0 \SetRowColor{LightBackground} {\bf{Subtypes}} & {\bf{Mechanism of action}} \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} {\bf{α1 adrenoceptors}} & {\bf{Postsynaptic}} - mediate effect on sympathetic nerve system (smooth muscle tissues + organs + blood vessels)) \tn % Row Count 6 (+ 5) % Row 2 \SetRowColor{LightBackground} {\bf{α2 adrenoceptors}} & {\bf{Presynaptic}} - out of synapse (mediat effects on catecholamines released from adrenal medulla) \tn % Row Count 10 (+ 4) % Row 3 \SetRowColor{white} {\bf{β1 adrenoceptors}} & {\bf{Postsynaptic}} - mediate effect on sympathetic nerve system (heart) \tn % Row Count 13 (+ 3) % Row 4 \SetRowColor{LightBackground} {\bf{β2 adrenoceptors}} & {\bf{Presynaptic}} - out of synapse (mediate effects of catecholamines ccirculating in blood leads to vasodilation) \tn % Row Count 18 (+ 5) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Adreno-positive drugs}} \tn % Row 0 \SetRowColor{LightBackground} {\bf{α, β-adrenomimetics}} (natural - used intravenously) & {\bf{Epinephrine, norepinephrine}} \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} {\bf{α-adrenomimetics}} (selective) & {\bf{α1-adrenomimetics}} = {\bf{phenylephrine}} (increases BP locally + effective orally) \{\{nl\}\} {\bf{α2-adrenomimetics}} = {\bf{Naphazoline}}, {\bf{clonidine}} (decreases BP, antihypertensive drug) \tn % Row Count 13 (+ 10) % Row 2 \SetRowColor{LightBackground} {\bf{β-adrenomimetics}} (selective) & {\bf{β1,β2-adrenomimetics}} = {\bf{isoprenaline}} \{\{nl\}\} {\bf{β1-adrenomimetics}} = {\bf{dobutamine}} (if patient doesnt have hypoxia or ischemic disease) \{\{nl\}\} {\bf{β2-adrenomimetics}} = {\bf{salbutamol}} (short acting drug), {\bf{phenoterol}}, {\bf{salmeterol}} (slow/prolonged acting drug) \tn % Row Count 27 (+ 14) % Row 3 \SetRowColor{white} {\bf{Sympathomimetics}} (indirect binding on receptors) & {\bf{Ephedrine}} (acts on sypathetic endings, stimulates release of norepinephrine, indirectly produces efftecs on post synaptic receptors) \tn % Row Count 34 (+ 7) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Adreno-negative drugs}} \tn % Row 0 \SetRowColor{LightBackground} {\bf{Adrenoblockers/adrenoceptors antagonists}} (direct binding on receptors) & {\bf{α, β-adrenoblockers}} (natural) - {\bf{Labetalol}} \{\{nl\}\} {\bf{α-adrenoblockers}} - {\bf{α1,α2-adrenoblockers}} (non-selective) - {\bf{Phentolamine}}, dihydroergotamine \{\{nl\}\} {\bf{α1-adrenoblockers}} - \{\{nl\}\} {\bf{α1a-adrenoblockers}} - {\bf{tamsulosin}} \{\{nl\}\} {\bf{α1b-adrenoblockers}} - {\bf{prazosin}} \tn % Row Count 15 (+ 15) % Row 1 \SetRowColor{white} & {\bf{β- Adrenoblockers / adrenoceptor antagonists}} \{\{nl\}\} {\bf{β1,β2-Adrenoblockers}} (non-selective) - {\bf{Propranolol}}, timolol \{\{nl\}\} {\bf{β1-adrenoblockers}} - {\bf{atenolol, metrolol}} \tn % Row Count 25 (+ 10) % Row 2 \SetRowColor{LightBackground} {\bf{Sympatholytics}} (indrect binding on receptors) & {\bf{Reserpine}}, guanethidine \tn % Row Count 28 (+ 3) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{1.4931 cm} x{3.4839 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Indications + side effects}} \tn % Row 0 \SetRowColor{LightBackground} α \seqsplit{adrenomimetics} & Pharmacological effects - Vasoconstriction of blood vessels \{\{nl\}\} Mydriasis \{\{nl\}\} Decrease NA peripheral \tn % Row Count 4 (+ 4) % Row 1 \SetRowColor{white} β \seqsplit{adrenomimetics} & {\bf{Indications}} - Bronchial asthma, uterine relaxation (preserving pregnancy) \{\{nl\}\} {\bf{pharmacological effects}} - cause dilation of brochial passages, \{\{nl\}\} Vasodilation in muscle and liver, \{\{nl\}\} Relaxaion of uterine muscle, \{\{nl\}\} Release of insulin \tn % Row Count 14 (+ 10) % Row 2 \SetRowColor{LightBackground} α \seqsplit{adrenoblockers} & {\bf{Side effects }} - hypotension \{\{nl\}\} Tachycardia \tn % Row Count 16 (+ 2) % Row 3 \SetRowColor{white} β \seqsplit{adrenoblockers} & {\bf{Mechanism of action of antihypertensive action of beta adrenoblockers}} - decrease cardiac output \{\{nl\}\} Decrease renin secretion \{\{nl\}\} reduce central sympathetic activity (selective BB)) \{\{nl\}\} {\bf{Side effects \{\{nl\}\} Side effects β2 AB}} - {\emph{Heart insufficiency}}, {\emph{bronchoconstriction}}, *hypoglycemia*, fatigue, dizziness, nausea, diarrhea \{\{nl\}\} Side effects β1 AB - \tn % Row Count 30 (+ 14) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Specific drugs}} \tn % Row 0 \SetRowColor{LightBackground} {\bf{Phentolamine}} (anatgonises α1+2 adrenoceptors) & Decreases BP caused by adrenaline, affects -ive feedback mechanism (α2-adrenoceptors) in the synapse \{\{nl\}\} {\bf{Indications}} - Pheochromocytoma (adrenal gland tumour) + endarteritis (inflammation of arteries, legs \{\{nl\}\} {\bf{Side effects}} - Orthostatic (standing) collapse (severe drop in BP) + tachycardia \{\{nl\}\} reverse effects of adrenaline on BP \tn % Row Count 18 (+ 18) % Row 1 \SetRowColor{white} {\bf{Tamsulosin}} (Selectively anatgonises/blocks α1A-adrenoceptors) & {\bf{Indication}} - benign prostate hyperplasia (increased cell production in a normal tissue or organ) \{\{nl\}\} Relax smooth muscle of prostate gland \{\{nl\}\} Help to decrease these symptoms \tn % Row Count 28 (+ 10) % Row 2 \SetRowColor{LightBackground} {\bf{Prazosin}} (Selectively atangonises/blocks α1B-adrenoceptors in bood vessels) & Does not affect the -ive feedback mechanism in synapse \{\{nl\}\} {\bf{Indication}} - arterial hypertension \{\{nl\}\} {\bf{Side effect}} - othostatic collapse \tn % Row Count 36 (+ 8) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Specific drugs}} \tn % Row 0 \SetRowColor{LightBackground} {\bf{Propanolol}} - Non-selective β1,β2-adrenoblocker & Decrease heart output, decrease activity of SA + AV nodes, decrease BP due to action on: \{\{nl\}\} Heart - decreases heart output \{\{nl\}\} Kidney (propanolol decreases production production of renin in the kidney \{\{nl\}\} CNS (decrease sympathetic activity on PNS)) \tn % Row Count 13 (+ 13) % Row 1 \SetRowColor{white} {\bf{Atenolol, Metoprolol}} (Selective β1-Adrenoblocker) & Cardioselective in therapeutic doses \{\{nl\}\} drugs of choice in cardiac patients \tn % Row Count 17 (+ 4) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} % That's all folks \end{multicols*} \end{document}